Buttram v. Owens-Corning Fiberglas Corp.

941 P.2d 71, 62 Cal. Comp. Cases 1031, 16 Cal. 4th 520, 97 Daily Journal DAR 10671, 97 Cal. Daily Op. Serv. 6549, 1997 Cal. LEXIS 4417, 66 Cal. Rptr. 2d 438
CourtCalifornia Supreme Court
DecidedAugust 18, 1997
DocketS046375
StatusPublished
Cited by56 cases

This text of 941 P.2d 71 (Buttram v. Owens-Corning Fiberglas Corp.) is published on Counsel Stack Legal Research, covering California Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Buttram v. Owens-Corning Fiberglas Corp., 941 P.2d 71, 62 Cal. Comp. Cases 1031, 16 Cal. 4th 520, 97 Daily Journal DAR 10671, 97 Cal. Daily Op. Serv. 6549, 1997 Cal. LEXIS 4417, 66 Cal. Rptr. 2d 438 (Cal. 1997).

Opinions

[524]*524Opinion

BAXTER, J.

I. Introduction.

Defendant and appellant Owens-Coming Fiberglas Corporation (OCF) appealed from a products liability judgment in the amount of $1,519,475 entered against it in a trial involving plaintiff and respondent James But-tram’s exposure to OCF’s asbestos-containing products and his consequent contraction of pleural mesothelioma, an asbestos-caused form of lung cancer. In an order filed on October 17,1996, we designated this matter the lead case for deciding the issue of when a cause of action seeking damages for personal injuries resulting from a latent disease such as asbestos-related mesothelioma accrues for purposes of determining whether the provisions of Proposition 51 can be prospectively applied.

Proposition 51, effective June 4, 1986, modified the common law mle of joint and several liability by limiting a tortfeasor’s liability for noneconomic damages1 to the proportion of such damages equal to the tortfeasor’s own percentage of fault. In Evangelatos v. Superior Court (1988) 44 Cal.3d 1188, 1193-1194, 1205 [246 Cal.Rptr. 629, 753 P.2d 585] (Evangelatos), we held Proposition 51 prospective only and applicable only to causes of action “accruing” on or after its effective date. (See Civ. Code, § 1431.2.)

In a posttrial motion, OCF argued Proposition 51 should be applied to this case to limit its liability for plaintiff’s award of noneconomic damages ($450,000) to the proportion of such damages equal to its own percentage of fault. The trial court determined that because plaintiff’s medical testimony established that undetected cancer cells in probability had started forming by 1984, two years prior to the effective date of Proposition 51, plaintiff’s cause of action for injuries arising from pleural mesothelioma “accrued” prior to the initiative measure’s effective date. The trial court therefore ruled Proposition 51 ’s tort reform measures inapplicable to this case, leaving OCF jointly and severally liable for the entire award of noneconomic damages.

The Court of Appeal affirmed, concluding that for purposes of determining whether Proposition 51 applied, plaintiff’s cause of action for damages resulting from the latent asbestos-related disease mesothelioma accrued [525]*525“when he suffered some sort of appreciable, meaning compensable, harm or injury.” Under the Court of Appeal’s test, subclinical (i.e., undiscovered and unmanifested) cellular changes, such as development of the first cancer cell, constitute the “appreciable harm” that triggers accrual of a cause of action for Proposition 51 purposes in the latent disease context. It matters not that plaintiff did not suffer any actual symptoms of the disease, was unaware he would contract the disease, and was not diagnosed with the disease at the time the undetected cellular changes first occurred. Under the rationale of the Court of Appeal’s holding, as long as plaintiff’s medical experts can establish, in retrospect, that such subclinical cellular changes began forming at some time prior to the effective date of Proposition 51, the initiative’s tort reform measures are rendered inapplicable in a case involving latent injuries.

For the reasons explained below, we reject the Court of Appeal’s test for determining when a plaintiff’s cause of action accrues for purposes of applying Proposition 51 in the latent disease context. We hold instead that a cause of action for damages arising from the latent and progressive asbestos-related disease mesothelioma has “accrued”—for purposes of determining whether Proposition 51 can be prospectively applied consistent with the rationale of this court’s holding in Evangelatos, supra, 44 Cal.3d 1188—if the plaintiff was diagnosed with the disease for which damages are being sought, or otherwise discovered his illness or injuries, prior to Proposition 51’s effective date of June 4, 1986.

II. Factual and Procedural Background.

Since OCF did not challenge the sufficiency of the evidence to support the liability or damage verdicts in issue on appeal, we need not review the voluminous record in great detail. The following salient facts were found relevant to the Proposition 51 “accrual” issue by the Court of Appeal.

Plaintiff is a Vietnam veteran who served from 1964 to 1968 in the United States Navy. He was assigned to the destroyer U.S.S. Mullaney and, both while the ship was in dry dock for repairs and during its active service in Vietnam, frequently worked in the ship’s boiler room. The boilers and steam pipes in the boiler room were all insulated with asbestos, and plaintiff was present in that room when the insulation was both being removed and repaired. Also, when the ship was conducting shore bombardment off the coast of Vietnam during its active service, vibration from the ship’s guns caused breaks in the asbestos insulation and pipes in the boiler room, which plaintiff would also have to repair.

After plaintiff left the Navy in 1968, he had no further work with or exposure to asbestos-containing materials. Commencing in 1978, he worked [526]*526as a maintenance mechanic with a chemical manufacturer. In 1991, at age 47, he had a routine annual physical examination which included a chest X-ray that revealed a problem with one of his lungs. After a series of tests at Kaiser Hospital, a biopsy revealed he had contracted pleural mesothelioma. He was advised there was no cure for this disease, and he would eventually die from it.

Subsequently, plaintiff had a lung removed, was given electric shock therapy to slow down his heart rate, and underwent chemotherapy. He filed suit on July 2, 1992, and several months later the trial court granted his motion for trial preference under Code of Civil Procedure section 36. Settlements were effectuated with several named defendants soon thereafter, and a trial as to OCF followed the next year.

In pretrial motions, OCF argued Proposition 51 should apply to the case. Plaintiff in turn urged that the initiative measure did not apply because both the wrongful conduct and the early stages of his injury predated Proposition 51’s effective date. Plaintiff agreed to proceed to trial as though Proposition 51 applied, reserving the issue for a posttrial ruling.

After a bifurcated trial (phase I addressing causation and compensatory damages, phase II addressing exposure and liability issues), the jury returned a verdict in plaintiff’s favor and awarded him damages totaling $1,519,475. Of this amount, $450,000 was allocated by the jury as noneconomic damages. The jury found OCF’s percentage of fault to be 28 percent. In a third phase of the trial, the jury declined to award plaintiff any punitive damages against OCF.

The parties filed posttrial cross-motions with respect to the issue of the applicability of Proposition 51 to the case. Based on the unrebutted medical testimony of Dr. Barry Horn, the trial court determined plaintiff probably had subclinical cancer cell formation at least seven years before the discovery of fluid in his lungs in 1991. The court held that plaintiff’s cause of action therefore “accrued,” for purposes of Proposition 51, at the time of such asymptomatic cancer cell formation, and that since Proposition 51 was prospective only under this court’s holding in Evangelatos, supra, 44 Cal.3d 1188, it did not apply to plaintiff’s case.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Brewer v. Impact Biomedicines CA4/1
California Court of Appeal, 2025
Izard v. The Scripps Research Institute CA4/1
California Court of Appeal, 2024
Goldstein v. SF Holding Company CA2/4
California Court of Appeal, 2024
Elation Systems, Inc. v. Fenn Bridge LLC
California Court of Appeal, 2021
B.B. v. County of Los Angeles
California Supreme Court, 2020
Baxter v. Cal. State Teachers' Ret. Sys.
227 Cal. Rptr. 3d 37 (California Court of Appeals, 5th District, 2017)
City of Pasadena v. Super. Ct.
California Court of Appeal, 2017
City of Pasadena v. Superior Court of L. A. Cnty.
220 Cal. Rptr. 3d 99 (California Court of Appeals, 5th District, 2017)
Lopez v. Sony Electronics, Inc.
247 Cal. App. 4th 444 (California Court of Appeal, 2016)
Woody's Group, Inc. v. City of Newport Beach
233 Cal. App. 4th 1012 (California Court of Appeal, 2015)
Cobb v. Ironwood Country Club
233 Cal. App. 4th 960 (California Court of Appeal, 2015)
Hanh Nguyen v. Western Digital Corp.
229 Cal. App. 4th 1522 (California Court of Appeal, 2014)
Studendorff v. National Semiconductor CA6
California Court of Appeal, 2014
Sutter Health v. Superior Court
227 Cal. App. 4th 1546 (California Court of Appeal, 2014)
Aryeh v. Canon Business Solutions, Inc.
292 P.3d 871 (California Supreme Court, 2013)
Leonard v. John Crane, Inc.
206 Cal. App. 4th 1274 (California Court of Appeal, 2012)
Vanhooser v. Superior Court
206 Cal. App. 4th 921 (California Court of Appeal, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
941 P.2d 71, 62 Cal. Comp. Cases 1031, 16 Cal. 4th 520, 97 Daily Journal DAR 10671, 97 Cal. Daily Op. Serv. 6549, 1997 Cal. LEXIS 4417, 66 Cal. Rptr. 2d 438, Counsel Stack Legal Research, https://law.counselstack.com/opinion/buttram-v-owens-corning-fiberglas-corp-cal-1997.